ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Potassium Iodide → (6R,7R)-3-[[5-amino-4-[[(2S)-5-amino-2-[(2-aminoacetyl)amino]pentanoyl]amino]-1-methylpyrazol-2-ium-2-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

HRID 459638
印刷

反応式

HRID 459638 の反応式
[NH2:1][C:2]1[S:6][N:5]=[C:4](/[C:7](=[N:34]/[O:35][C:36]([C:39]([O:41]C(C)(C)C)=[O:40])([CH3:38])[CH3:37])/[C:8]([NH:10][C@@H:11]2[C:32](=[O:33])[N:13]3[C:14]([C:20]([O:22]CC4C=CC(OC)=CC=4)=[O:21])=[C:15]([CH2:18]Cl)[CH2:16][S:17][C@H:12]23)=[O:9])[N:3]=1.C[Si](C)(C)NC(=O)C.[I-].[K+].C(OC([NH:63][CH2:64][C:65]([NH:67][C@H:68]([C:80]([NH:82][C:83]1[CH:84]=[N:85][N:86]([CH3:108])[C:87]=1[NH:88]C(C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)=[O:81])[CH2:69][CH2:70][CH2:71][NH:72]C(=O)OC(C)(C)C)=[O:66])=O)(C)(C)C>CN(C)C=O.C(OCC)(=O)C>[NH2:1][C:2]1[S:6][N:5]=[C:4](/[C:7](=[N:34]/[O:35][C:36]([C:39]([OH:41])=[O:40])([CH3:38])[CH3:37])/[C:8]([NH:10][C@@H:11]2[C:32](=[O:33])[N:13]3[C:14]([C:20]([O-:22])=[O:21])=[C:15]([CH2:18][N+:85]4[N:86]([CH3:108])[C:87]([NH2:88])=[C:83]([NH:82][C:80](=[O:81])[C@@H:68]([NH:67][C:65](=[O:66])[CH2:64][NH2:63])[CH2:69][CH2:70][CH2:71][NH2:72])[CH:84]=4)[CH2:16][S:17][C@H:12]23)=[O:9])[N:3]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 4875Potassium IodideHCID 25989Acetamide, N-(trimethylsilyl)-HCID 86597891tert-butyl (4S)-4-{[2-(tert-butoxycarbonylamino)acetyl]amino}-5-{[1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]amino}-5-oxopentylcarbamateHCID 87481325Ceftolozane Impurity 20

生成物 1

HCID 141612445
(6R,7R)-3-[[5-amino-4-[[(2S)-5-amino-2-[(2-aminoacetyl)amino]pentanoyl]amino]-1-methylpyrazol-2-ium-2-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
収率 4.2%

試薬・触媒・溶媒 2

HCID 6228Dimethylformamide溶媒HCID 8857Ethyl Acetate溶媒

実験手順

To a solution of 4-methoxybenzyl 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-tert-butoxycarbonyl-1-methylethoxyimino)acetamido]-3-chloromethyl-3-cephem-4-carboxylate (1.0 g) in N,N-dimethylformamide (3 ml) was added N-(trimethylsilyl)acetamide (965 mg) and the mixture was stirred at room temperature for 30 minutes. To the solution was added potassium iodide (341 mg) and the mixture was stirred at room temperature for 30 minutes. To the reaction mixture was added tert-butyl (4S)-4-{[2-(tert-butoxycarbonylamino)acetyl]amino}-5-{[1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]amino}-5-oxopentylcarbamate (1.27 g), and the whole mixture was stirred at 40° C. for 4 hours. To the reaction mixture was added ethyl acetate (100 ml) and the mixture was washed successively with brine (50 ml), 10% aqueous sodium trifluoroacetate solution (50 ml) and brine (50 ml), dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated to about 5 ml in vacuo. The concentrate was poured into diisopropyl ether (120 ml) and the resulting precipitate was collected by filtration and dried in vacuo. To a solution of the solid in methylene chloride (4.5 ml) were added anisole (1.5 ml) and trifluoroacetic acid (3.0 ml). The resulting solution was stirred at room temperature for 16 hours and poured into diisopropyl ether (120 ml). The resulting precipitate was collected by filtration and dried in vacuo to give a crude product (1.42 g), which was purified by preparative HPLC utilizing ODS column. The eluate containing a desired product was concentrated to about 20 ml in vacuo. The concentrate was further purified by preparative HPLC utilizing ODS column eluting with 8% acetonitrile/water. The eluate was concentrated to about 10 ml in vacuo. The resulting solution was lyophilized to give 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido]-3-[3-amino-4-({(2S)-5-amino-2-[(aminoacetyl)amino]pentanoyl}amino)-2-methyl-1-pyrazolio]methyl-3-cephem-4-carboxylate (46.3 mg) as an amorphous solid.

後処理

  1. stirringthe mixture was stirred at room temperature for 30 minutes
  2. stirringthe whole mixture was stirred at 40° C. for 4 hours
  3. washthe mixture was washed successively with brine (50 ml), 10% aqueous sodium trifluoroacetate solution (50 ml) and brine (50 ml)
  4. dry with materialdried over anhydrous magnesium sulfate
  5. filtrationfiltered
  6. concentrationThe filtrate was concentrated to about 5 ml in vacuo
  7. additionThe concentrate was poured into diisopropyl ether (120 ml)
  8. filtrationthe resulting precipitate was collected by filtration
  9. customdried in vacuo
  10. additionTo a solution of the solid in methylene chloride (4.5 ml) were added anisole (1.5 ml) and trifluoroacetic acid (3.0 ml)
  11. stirringThe resulting solution was stirred at room temperature for 16 hours
  12. additionpoured into diisopropyl ether (120 ml)
  13. filtrationThe resulting precipitate was collected by filtration
  14. customdried in vacuo
  15. customto give a crude product (1.42 g), which
  16. customwas purified by preparative HPLC
  17. additionThe eluate containing a desired product
  18. concentrationwas concentrated to about 20 ml in vacuo
  19. customThe concentrate was further purified by preparative HPLC
  20. washeluting with 8% acetonitrile/water
  21. concentrationThe eluate was concentrated to about 10 ml in vacuo

出典と根拠

ORDレコード
ord-c5be349dd10148638646fc153a07421d
出典データセット
uspto-grants-2007_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07192943B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート